133 related articles for article (PubMed ID: 35319510)
1. Extramedullary Infiltration in Pediatric Acute Myeloid Leukemia on Surveillance Magnetic Resonance Imaging and its Relationship With Established Risk Factors.
Kim EH; Im SA; Lee JW; Kim S; Cho B
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e713-e718. PubMed ID: 35319510
[TBL] [Abstract][Full Text] [Related]
2. Extramedullary infiltration in pediatric acute myeloid leukemia: Results from the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative.
Li W; Shi M; Zhou P; Liu Y; Liu X; Xiao X; Zuo S; Bai Y; Sun K
Pediatr Blood Cancer; 2024 Jul; 71(7):e31014. PubMed ID: 38644612
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Extramedullary Infiltration in Pediatric Low-risk Acute Myeloid Leukemia: A Retrospective Single-center Study Over 10 Years.
Hu GH; Lu AD; Jia YP; Zuo YX; Wu J; Zhang LP
Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e813-e820. PubMed ID: 32680776
[TBL] [Abstract][Full Text] [Related]
4. Children with acute myeloblastic leukemia presenting with extramedullary infiltration: the effects of high-dose steroid treatment.
Hiçsönmez G; Cetin M; Tuncer AM; Yenicesu I; Aslan D; Ozyürek E; Unal S
Leuk Res; 2004 Jan; 28(1):25-34. PubMed ID: 14630077
[TBL] [Abstract][Full Text] [Related]
5. Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia.
Kobayashi R; Tawa A; Hanada R; Horibe K; Tsuchida M; Tsukimoto I;
Pediatr Blood Cancer; 2007 Apr; 48(4):393-8. PubMed ID: 16550530
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Role of Postinduction Minimal Residual Disease and Myeloid Sarcoma Type Extramedullary Involvement in Pediatric RUNX1-RUNX1T1 (+) Acute Myeloid Leukemia.
Lee JW; Kim S; Jang PS; Chung NG; Cho B; Im SA; Kim M
J Pediatr Hematol Oncol; 2020 Apr; 42(3):e132-e139. PubMed ID: 31688618
[TBL] [Abstract][Full Text] [Related]
7. High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group.
Shimada A; Taki T; Koga D; Tabuchi K; Tawa A; Hanada R; Tsuchida M; Horibe K; Tsukimoto I; Adachi S; Kojima S; Hayashi Y
Int J Hematol; 2012 Oct; 96(4):469-76. PubMed ID: 22915059
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features and prognostic factors in adult acute myeloid leukemia patients with FLT3-ITD and CEBPA gene co-mutation].
Pei RR; Zhang RH; Yu JF; Jiang ZX; Sun H; Wan DM; Xie XS; Liu YF; Li T; Sun L
Zhonghua Xue Ye Xue Za Zhi; 2020 Apr; 41(4):297-301. PubMed ID: 32447933
[No Abstract] [Full Text] [Related]
9. Circular RNA regulatory network reveals cell-cell crosstalk in acute myeloid leukemia extramedullary infiltration.
Lv C; Sun L; Guo Z; Li H; Kong D; Xu B; Lin L; Liu T; Guo D; Zhou J; Li Y
J Transl Med; 2018 Dec; 16(1):361. PubMed ID: 30558617
[TBL] [Abstract][Full Text] [Related]
10. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
[TBL] [Abstract][Full Text] [Related]
11. Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience.
Fianchi L; Quattrone M; Criscuolo M; Bellesi S; Dragonetti G; Maraglino AME; Bonanni M; Chiusolo P; Sica S; Pagano L
Mediterr J Hematol Infect Dis; 2021; 13(1):e2021030. PubMed ID: 34007418
[TBL] [Abstract][Full Text] [Related]
12. [FLT3 gene overexpression and its clinical significance in acute myeloid leukemia with AML1/ETO fusion gene positive].
Xie HM; Gao L; Wang N; Xu YY; Shi JL; Yu L; Wang LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1199-205. PubMed ID: 25338557
[TBL] [Abstract][Full Text] [Related]
13. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
14. [Detection of NPM1, FLT3 and C-KIT mutations in acute myeloid leukemia and their prognostic analysis].
Li L; Lyu XD; Mi RH; Ding J; Chen L; Wang Q; Yin QS; Hu JY; Fan RH; Wei XD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):601-6. PubMed ID: 23815906
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics of newly diagnosed acute myeloid leukemia patients with NPM1 mutation].
Wei H; Zhang YQ; Lin D; Wang Y; Zhou CL; Liu BC; Li W; Rao Q; Wang M; Mi YC; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):11-5. PubMed ID: 24598642
[TBL] [Abstract][Full Text] [Related]
16. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
[TBL] [Abstract][Full Text] [Related]
17. T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Canaani J; Labopin M; Huang XJ; Arcese W; Ciceri F; Blaise D; Irrera G; Corral LL; Bruno B; Santarone S; Van Lint MT; Vitek A; Esteve J; Mohty M; Nagler A
Am J Hematol; 2018 Jun; 93(6):736-744. PubMed ID: 29498106
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Impact of Concurrent DNMT3A, FLT3 and NPM1 Gene Mutations in Acute Myeloid Leukemia Patients.
Elrhman HAEA; El-Meligui YM; Elalawi SM
Clin Lymphoma Myeloma Leuk; 2021 Dec; 21(12):e960-e969. PubMed ID: 34376373
[TBL] [Abstract][Full Text] [Related]
19. [Detection and clinical significance of FLT3-ITD gene mutation in patients with acute myeloid leukemia].
Xu YY; Gao L; Ding Y; Sun JZ; Wang N; Wang LL; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1312-5. PubMed ID: 23257423
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of EZH2 in Acute Myeloid Leukemia.
Jiao W; Liu Y; Bao Y
Comput Intell Neurosci; 2022; 2022():8741989. PubMed ID: 36052036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]